title: Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients.
authors.affiliation: Departments of Transplantation/Vascular Surgery, New York Medical College, Valhalla, New York, USA.
authors.forename: R
authors.initials: R
authors.lastname: El-Sabrout
authors.forename: R
authors.initials: R
authors.lastname: Weiss
authors.forename: F
authors.initials: F
authors.lastname: Butt
authors.forename: V
authors.initials: V
authors.lastname: Delaney
authors.forename: M
authors.initials: M
authors.lastname: Qadir
authors.forename: P
authors.initials: P
authors.lastname: Hanson
authors.forename: K
authors.initials: K
authors.lastname: Butt
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D009518:New York; D012086:Reoperation / Q000706:statistics & numerical data; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus